Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
PROJECT ABSTRACT
Program Overview
This is a single consolidated U2C/TL1 training program (the Learners to LeAders in benign Urology, benign
Nephrology, and non-Cancer Hematology [LAUNCH] Program) that seeks to integrate, expand, and transform
kidney, urologic, and hematologic (KUH) biomedical research training in Northern California. Based at four
institutions with outstanding research resources and training accomplishments—University of California San
Francisco (UCSF), University of California Berkeley (UC Berkeley), University of California Davis (UC Davis),
and Stanford University—we propose an innovative approach to train 22 (4 pre- and 18 post-doctoral) trainees
annually across adult and pediatric KUH disciplines. We will identify and recruit the most promising and diverse
group of trainees to enable them to conduct KUH research and provide these LAUNCH Program trainees with
outstanding basic, translational, or clinical research training. Our overall goal is to establish a unified training
program that promotes interdisciplinary collaboration and training of the most promising junior investigators
across our four institutions. Thus, we expect that the LAUNCH Program will graduate scientists who are well-
trained, able to compete successfully for research funding, and able to think creatively and collaboratively to
generate novel and impactful science. The LAUNCH Program will be led by the U2C multi-PI’s (Drs. Elaine
Ku, Marshall Stoller, and Kathleen Sakamoto) as well as the TL1 multi-PI’s (Drs. Chi-yuan Hsu, Philip Beachy,
and Mark Walters), each of whom possess complementary expertise in research and research training within
the disciplines of nephrology, urology, and hematology. The world-class training faculty whom we have
included in our program were selected not only based on their own scientific and scholarly achievements but
also their track record of mentorship and commitment to training. The LAUNCH Program is modeled after
several highly-successful training programs at our institutions that have trained numerous exceptional
scientists from a wide range of disciplines using a team science approach.
Public Health Relevance Statement
PROJECT NARRATIVE
The mission of our LAUNCH Program is to provide research training to talented trainees who are poised to
become the future leaders of scientific inquiry in nephrology, urology, and hematology. Our proposed
LAUNCH Program will aim to train 22 trainees annually and prepare these pre- and post-doctoral individuals to
become well-rounded scientists equipped with the skillsets they need to thrive in successful research careers.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
01-September-2023
Project End Date
30-June-2028
Budget Start Date
01-September-2023
Budget End Date
30-June-2024
Project Funding Information for 2023
Total Funding
$832,601
Direct Costs
$656,094
Indirect Costs
$176,507
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Diabetes and Digestive and Kidney Diseases
$832,601
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U2CDK133488-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U2CDK133488-01A1
Patents
No Patents information available for 1U2CDK133488-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U2CDK133488-01A1
Clinical Studies
No Clinical Studies information available for 1U2CDK133488-01A1
News and More
Related News Releases
No news release information available for 1U2CDK133488-01A1
History
No Historical information available for 1U2CDK133488-01A1
Similar Projects
No Similar Projects information available for 1U2CDK133488-01A1